Literature DB >> 18826518

Prediction and reverse prediction in therapeutics and toxicology.

J M Ritter.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18826518      PMCID： PMC2561124          DOI： 10.1111/j.1365-2125.2008.03293.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  17 in total

1.  Enzymatic metabolism of drugs and other foreign compounds.

Authors:  B B BRODIE; J R GILLETTE; B N LA DU
Journal:  Annu Rev Biochem       Date:  1958       Impact factor: 23.643

2.  Classifying drug interactions.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2004-10       Impact factor: 4.335

3.  Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors.

Authors:  N J Proctor; G T Tucker; A Rostami-Hodjegan
Journal:  Xenobiotica       Date:  2004-02       Impact factor: 1.908

4.  Backtracking booze with Bayes--the retrospective interpretation of blood alcohol data.

Authors:  P R Jackson; G T Tucker; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

5.  Prediction of in vivo drug-drug interactions from in vitro data: impact of incorporating parallel pathways of drug elimination and inhibitor absorption rate constant.

Authors:  Hayley S Brown; Kiyomi Ito; Aleksandra Galetin; J Brian Houston
Journal:  Br J Clin Pharmacol       Date:  2005-11       Impact factor: 4.335

6.  Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise.

Authors:  Robinson Joannides; Nicholas Moore; Michaela Iacob; Patricia Compagnon; Guy Lerebours; Jean-François Menard; Christian Thuillez
Journal:  Br J Clin Pharmacol       Date:  2006-02       Impact factor: 4.335

7.  Reduction of oxidative stress and modulation of autoantibodies against modified low-density lipoprotein after rosuvastatin therapy.

Authors:  Ulrike Resch; Franz Tatzber; Alexandra Budinsky; Helmut Sinzinger
Journal:  Br J Clin Pharmacol       Date:  2006-03       Impact factor: 4.335

Review 8.  Post-mortem clinical pharmacology.

Authors:  R E Ferner
Journal:  Br J Clin Pharmacol       Date:  2008-05-29       Impact factor: 4.335

Review 9.  What lessons can be learnt from withdrawal of mibefradil from the market?

Authors:  A L Po; W Y Zhang
Journal:  Lancet       Date:  1998-06-20       Impact factor: 79.321

10.  Maraviroc: in vitro assessment of drug-drug interaction potential.

Authors:  Ruth Hyland; Maurice Dickins; Claire Collins; Hannah Jones; Barry Jones
Journal:  Br J Clin Pharmacol       Date:  2008-04-10       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.